OR WAIT null SECS
May 06, 2020
CMO Evonik begins capacity expansion of APIs and intermediates at its sites in Dossenheim and Hanau Germany to increase EU supply security for drug products.
April 23, 2020
Wavelength Pharmaceuticals expanded production of APIs for certain pharmaceutical products needed to manage respiratory critical care patients in the COVID-19 pandemic.
April 15, 2020
Civica Rx plans redundant manufacturing capacity to relieve and prevent shortages of generic, sterile injectable drugs.
April 08, 2020
The agency has been tasked with coordinating efforts to mitigate shortages of medicines within Europe during the COVID-19 pandemic.
April 02, 2020
More sustainable and functional packaging protects temperature-sensitive drugs.
As COVID-19 rapidly spreads, the bio/pharma industry is committing significant efforts to fast track development of therapies.
Pharmaceutical Technology spoke with Jens Andersson, purchasing director at Cambrex Karlskoga, about the best way to ensure the security of the bio/pharmaceutical materials supply chain.
Risk assessments, audits, and good communication between sponsor and supplier are key elements of supplier oversight.
March 27, 2020
Data and analytics company GlobalData announced that there is a strain on the global biopharma industry’s supply chain due to the ongoing outbreak of COVID-19.